These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
592 related articles for article (PubMed ID: 32881907)
1. Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight. Khan MI; Khan ZA; Baig MH; Ahmad I; Farouk AE; Song YG; Dong JJ PLoS One; 2020; 15(9):e0238344. PubMed ID: 32881907 [TBL] [Abstract][Full Text] [Related]
2. From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes. Kandeel M; Ibrahim A; Fayez M; Al-Nazawi M J Med Virol; 2020 Jun; 92(6):660-666. PubMed ID: 32159237 [TBL] [Abstract][Full Text] [Related]
3. Properties of Coronavirus and SARS-CoV-2. Malik YA Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926 [TBL] [Abstract][Full Text] [Related]
4. The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19. Yoshimoto FK Protein J; 2020 Jun; 39(3):198-216. PubMed ID: 32447571 [TBL] [Abstract][Full Text] [Related]
5. Isolation of SARS-CoV-2-related coronavirus from Malayan pangolins. Xiao K; Zhai J; Feng Y; Zhou N; Zhang X; Zou JJ; Li N; Guo Y; Li X; Shen X; Zhang Z; Shu F; Huang W; Li Y; Zhang Z; Chen RA; Wu YJ; Peng SM; Huang M; Xie WJ; Cai QH; Hou FH; Chen W; Xiao L; Shen Y Nature; 2020 Jul; 583(7815):286-289. PubMed ID: 32380510 [TBL] [Abstract][Full Text] [Related]
6. Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CL Chitranshi N; Gupta VK; Rajput R; Godinez A; Pushpitha K; Shen T; Mirzaei M; You Y; Basavarajappa D; Gupta V; Graham SL J Transl Med; 2020 Jul; 18(1):278. PubMed ID: 32646487 [TBL] [Abstract][Full Text] [Related]
7. The genetic sequence, origin, and diagnosis of SARS-CoV-2. Wang H; Li X; Li T; Zhang S; Wang L; Wu X; Liu J Eur J Clin Microbiol Infect Dis; 2020 Sep; 39(9):1629-1635. PubMed ID: 32333222 [TBL] [Abstract][Full Text] [Related]
8. Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses. Gussow AB; Auslander N; Faure G; Wolf YI; Zhang F; Koonin EV Proc Natl Acad Sci U S A; 2020 Jun; 117(26):15193-15199. PubMed ID: 32522874 [TBL] [Abstract][Full Text] [Related]
9. Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week. Troyano-Hernáez P; Reinosa R; Holguín Á Viruses; 2021 Feb; 13(2):. PubMed ID: 33557213 [TBL] [Abstract][Full Text] [Related]
10. Structural and Evolutionary Analysis Indicate That the SARS-CoV-2 Mpro Is a Challenging Target for Small-Molecule Inhibitor Design. Bzówka M; Mitusińska K; Raczyńska A; Samol A; Tuszyński JA; Góra A Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32353978 [TBL] [Abstract][Full Text] [Related]
11. In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus. Eleftheriou P; Amanatidou D; Petrou A; Geronikaki A Molecules; 2020 May; 25(11):. PubMed ID: 32485894 [TBL] [Abstract][Full Text] [Related]
12. Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches. Bhowmik D; Nandi R; Jagadeesan R; Kumar N; Prakash A; Kumar D Infect Genet Evol; 2020 Oct; 84():104451. PubMed ID: 32640381 [TBL] [Abstract][Full Text] [Related]
13. Structure-based lead optimization of herbal medicine rutin for inhibiting SARS-CoV-2's main protease. Huynh T; Wang H; Luan B Phys Chem Chem Phys; 2020 Nov; 22(43):25335-25343. PubMed ID: 33140777 [TBL] [Abstract][Full Text] [Related]
14. Corona virus versus existence of human on the earth: A computational and biophysical approach. Zehra Z; Luthra M; Siddiqui SM; Shamsi A; Gaur NA; Islam A Int J Biol Macromol; 2020 Oct; 161():271-281. PubMed ID: 32512089 [TBL] [Abstract][Full Text] [Related]
15. An overall picture of SARS coronavirus (SARS-CoV) genome-encoded major proteins: structures, functions and drug development. Chen S; Luo H; Chen L; Chen J; Shen J; Zhu W; Chen K; Shen X; Jiang H Curr Pharm Des; 2006; 12(35):4539-53. PubMed ID: 17168760 [TBL] [Abstract][Full Text] [Related]
17. Decoding SARS-CoV-2 Transmission and Evolution and Ramifications for COVID-19 Diagnosis, Vaccine, and Medicine. Wang R; Hozumi Y; Yin C; Wei GW J Chem Inf Model; 2020 Dec; 60(12):5853-5865. PubMed ID: 32530284 [TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of Basu BV; Brown OR Front Biosci (Landmark Ed); 2020 Jun; 25(10):1894-1900. PubMed ID: 32472763 [TBL] [Abstract][Full Text] [Related]
19. Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies. Ahmed SF; Quadeer AA; McKay MR Viruses; 2020 Feb; 12(3):. PubMed ID: 32106567 [TBL] [Abstract][Full Text] [Related]
20. Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins. Srinivasan S; Cui H; Gao Z; Liu M; Lu S; Mkandawire W; Narykov O; Sun M; Korkin D Viruses; 2020 Mar; 12(4):. PubMed ID: 32218151 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]